Valibose

维力波糖

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameValibose
Drug Alias NameN/A
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesJoincare Pharmaceutical Group Industry Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesJoincare Pharmaceutical Group Industry Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A